Three foldasesÐthe apical domain of GroEL (mini-chaperone) and two oxidoreductases (DsbA and DsbC) from Escherichia coliÐwere studied in refolding a protein with immunoglobulin fold (immunoglobulin-folded protein) that had been produced as inclusion bodies in E.coli. The foldases promoted the refolding of single-chain antibody fragments from denaturant-solubilized and reduced inclusion bodies in vitro, and also effectively functioned as alternatives for labilizing agent and oxidizing reagent in the stepwise dialysis system. Immobilization of the oxidoreductases enhanced refolding and recovery of functional single-chain antibody in the dialysis system, suggesting that immobilized oxidoreductases can be used as an effective additive for refolding immunoglobulin-folded proteins in vitro.
Introduction
Recent advances in recombinant DNA technology have enabled the preparation of many therapeutically important proteins. Escherichia coli is a popular host for expression of recombinant proteins, due to its rapid growth and convenient handling. Overproduction of proteins, however, often leads to the formation of insoluble aggregates, referred to as inclusion bodies, in the cytoplasmic or periplasmic space of E.coli (Rudolph and Lilie, 1996; Clark, 1998; Misawa and Kumagai, 1999; Tsumoto et al., 2003) . To circumvent dif®culties in developing refolding procedures, several efforts have attempted to reduce inclusion body formation, e.g. lowered growth temperature, coexpression of molecular chaperones, disul®de isomerases or both (Yasukawa et al., 1995; Machida et al., 1998; Qiu et al., 1998; Schein and Noteborn, 1988; Kurokawa et al., 2000; Maskos et al., 2003) . However, the methods have produced only limited reductions in the amount of inclusion bodies.
Often, inclusion bodies consist mainly of the aggregated expressed proteins, with only minor contamination by lipids and nucleic acids. Thus, developing an ef®cient, convenient, economical method for refolding the aggregated protein into its native form would enable a large amount of functional protein to be recovered, suf®cient for industrial yields.
We recently reported a highly ef®cient refolding process for immunoglobulin-folded proteins using stepwise dialysis (Tsumoto et al., 1998; Asano et al., 2002a,b) . The most critical factors for highly ef®cient recovery of proteins from a denatured and reduced state are prevention of aggregation by adding labilizing agents and promotion of proper disul®de bond formation at the appropriate stage of refolding (Figure 1 ) (Tsumoto et al., 1998) . When the concentration of guanidium hydrochloride (GdnHCl) was decreased by stepwise dialysis, L-arginine (L-Arg) and oxidized glutathione (GSSG) were used as a labilizing agent and an oxidant, respectively, to attain a highly ef®cient yield of refolded protein. Recently, we carefully analyzed the pathway of the refolding process using various spectroscopic techniques and found that the timing of adding the agents critically in¯uences the formation of correct disul®de bonds (Umetsu et al., 2003) .
Here, we report the use of oxidoreductases instead of chemical reagents for in vitro refolding of antibody fragments obtained from the inclusion body. We tested whether three foldasesÐthe apical domain of GroEL (also called minichaperone) (Zahn et al., 1996) and two oxidoreductases (DsbA and DsbC) (Missiakas et al., 1994; Wunderlich et al., 1994; Zapun and Creighton, 1994) derived from E.coliÐcan be used for refolding the single-chain antibody variable domain fragments (scFvs) from a mouse anti-lysozyme monoclonal antibody, HyHEL-10. The scFv was refolded from a denatured and reduced state, and the suppression of protein aggregation and disul®de bond formation by the foldases was examined. The foldases were also compared with chemical reagents in our stepwise dialysis method. We also tested whether immobilized foldases could be used. We discuss the potential of oxidoreductases for refolding immunoglobulin-folded proteins.
Materials and methods

Materials
All enzymes for genetic engineering were obtained from Takara Shuzo (Kyoto, Japan), Toyobo (Osaka, Japan), Boehringer Mannheim (Mannheim, Germany) and New England Biolabs (Beverly, MA, USA). GdnHCl and isopropyl-b-D-thiogalactopyranoside (IPTG) were obtained from Wako Fine Chemicals Inc. (Osaka, Japan). All other reagents were of biochemical research grade. The HyHEL-10 scFv [VL±linker±VH±(His) 6 ] was prepared as described previously (Umetsu et al., 2003) . Construction of GroEL apical domain, DsbA and DsbC expression plasmids The gene encoding the GroEL apical domain (site 191±345 of E.coli GroEL) was ampli®ed by polymerase chain reaction (PCR), using 5¢-NNNCATATGGAAGGTATGCAGTTCGA-CCGTGGC-3¢ (NdeI site is underlined) and 5¢-NNN-GGATCCTTAACGGCCCTGGATTGCAGCTTC-3¢ (BamHI site is underlined) as primers and E.coli TG1 genome as template. The PCR product was digested with NdeI and BamHI, puri®ed, and cloned into the NdeI±BamHI site of pET15b (Novagen, USA). Each dsb gene (plus Shine±Dalgarno sequence) was ampli®ed by PCR using the E.coli TG1 genome as template and 5¢-NNNCATATGAAAAAGATTTGGCTG-GCG-3¢ (NdeI site is underlined) and 5¢-NNNGGATCC-TTATTTTTTCTCGGACAG-3¢ (BamHI site is underlined) as primers for dsbA and 5¢-NNNCATATGAAGAAAGGT-TTTATGTTGTTTACTTTG-3¢ and 5¢-NNNGGATCCTTA-TTTACCGCTGGTCATTTTTTGG-3¢ as primers for dsbC. The PCR product was digested with NdeI and BamHI, puri®ed, and cloned into the NdeI±BamHI site of pET-20b (Novagen).
Expression and preparation of the mini-chaperone, DsbA and DsbC The expression and puri®cation of the mini-chaperone were carried out as follows. E.coli strain BL21 (DE3) transformed with each expression vector was incubated at 28°C in Luria± Bertani (LB) broth. When the optical density reached 0.8 at 600 nm, 0.1 mM IPTG was added to the culture to induce protein production and the cells were grown overnight. Cells were separated from 1 l of culture by centrifugation (2000 g, 35 min) and resuspended in 10 ml of 50 mM Tris±HCl (pH 8.0) containing 150 mM NaCl. Cells were broken down by ultrasonication at 150 W for 15 min and centrifuged at 4500 g for 20 min. The soluble (formerly intracellular) fraction was passed over a Talon metal af®nity resin column (Clontech, Palo Alto, CA, USA). Minor impurities were removed by gel ®ltration on a Sephacryl S-200 column pre-equilibrated and eluted with 50 mM Tris±HCl (pH 8.0) containing 150 mM NaCl.
DsbA and DsbC were expressed as described above. Cell pellets were resuspended in 10 ml of 20 mM Tris±HCl (pH 7.5), 0.5 M sucrose and 0.1 mM EDTA and incubated for 5 min at room temperature. Then, 40 ml of water was added to give an osmotic shock and the cells were left on ice for 30 min. The cells were collected by centrifugation at 7000 g for 60 min at 4°C. The supernatant was salted out with 80% saturated ammonium sulfate and the precipitate was collected by centrifugation at 7000 g for 30 min. The protein precipitate was dissolved in 50 mM Tris±HCl (pH 8.0) containing 5 mM NaCl and was dialyzed against the same buffer for 2 days. The precipitate that formed during dialysis was removed by centrifugation at 10 000 g for 15 min. The supernatant was loaded onto a DEAE±Sepharose FF (Amersham Biosciences, Tokyo, Japan) column and the eluate was subjected to gel ®ltration on a Sephacryl S-200 column pre-equilibrated and eluted with 50 mM Tris±HCl (pH 8.0) containing 150 mM NaCl.
Immobilization of foldases
Wet N-hydroxysuccinimide-activated Sepharose 4FF (3 ml) (Amersham Biosciences) was washed with 50 ml of 1 mM HCl on an ice bath and then suspended in 50 mM NaHCO 3 (pH 8.0) containing 500 mM NaCl (coupling buffer). Foldases, preequilibrated with the coupling buffer, were added to the regin suspension (10 mg of protein per 1 ml of regin) and mixed gently overnight at 4°C. The resin was washed with the coupling buffer and any remaining active groups were blocked with ethanolamine; then the resin was washed according to the manufacturer's recommendations. The SH groups on the foldases were regenerated by incubation with 5 mM bmercaptoethanol (b-ME) at 4°C for 1 h. The resin was washed with the buffer and stored at 4°C. More than 95% of the foldases in the solution became immobilized and the resins were stable for more than 1 year at 4°C.
Measurement of chaperone-like activity
The chaperone-like activity (i.e. prevention of aggregation) of the mini-chaperone, DsbA and DsbC was determined by using denatured scFv as the substrate protein: scFv (15 mM) was chemically denatured in 6 M GdnHCl, 1 mM b-ME for more than 4 h at room temperature in the dark and the concentration of GdnHCl was brought to 2 M as described below. Enzyme activity was determined by the method of Umetsu et al. (2003) .
Disul®de isomerase activity of soluble and immobilized Dsbs
The disul®de isomerase activity of soluble and immobilized DsbA and DsbC was assayed according to Lyles and Gilbert (1991) , using scrambled bovine RNaseA as a substrate.
Ellman assay
DsbA, DsbC and scFv solutions were diluted to 1.5 mM protein concentration with 50 mM Tris±HCl buffer and then 50 ml of 10 mM 5,5¢-dithiobis(2-nitrobenzoic acid) (DTNB) solution (50 mM potassium phosphate buffer, pH 7.0, 1 mM EDTA) was added to 1.25 ml of the diluted protein solution. The number of free thiol groups was calculated from the monitoring of the absorbance at 412 nm after adding DTNB (Sadlak and Lindsay, 1968) .
Refolding of antibody fragments expressed as inclusion bodies
Dilution method. Puri®ed scFv fragments were denatured in 6 M GdnHCl, 1 mM b-ME for more than 4 h at room temperature in the dark (scFv concentration, 15 mM) and then the concentration of denaturant was adjusted to 2 M by dialysis. The scFv solution was diluted to the ®nal scFv and GdnHCl concentrations of 3 mM and 0.5 M, respectively, by a refolding solution (Wunderlich et al, 1994) .
Stepwise dialysis method. The scFv fragments denatured in 6 M GdnHCl were reduced by adding 357 mM b-ME (scFv concentration, 7.5 mM). The procedures for refolding insoluble antibody fragments were performed according to the method of Tsumoto et al. (1998) (stepwise dialysis method) except for adding the foldases instead of L-Arg and GSSG. According to the previous procedure (Tsumoto et al., 1998) , the concentration of GdnHCl in the dialysis buffer was phased down (3, 2, 1, 0.5 and 0 M). An oxidant (GSSG, DsbA or DsbC) and a reagent for preventing aggregate formation (0.4 M L-Arg or 375 mM mini-chaperone) were added when the dialysis buffer contained 1 or 0.5 M GdnHCl.
Functional characterization of refolded antibody fragments After the refolding procedure described above, the supernatants containing refolded proteins were concentrated tõ 10 mM with a Centriplus YM-10 ultra®ltration membrane (Millipore, Bedford, MA, USA). The concentrated scFv was puri®ed on a Superdex 75 pg (16 Q 400 mm) column equilibrated with 50 mM Tris±HCl (pH 7.5) containing 200 mM NaCl at 4°C, and dialyzed overnight against 50 mM phosphate buffer (pH 7.2) containing 200 mM NaCl. scFv binding was assayed essentially according to Ueda et al. (1993) . Various concentrations of Fv or scFv were mixed with 1.5 mM hen lysozyme in 30 ml of phosphate-buffered saline and incubated at 25°C for 1 h. Each mixture was then added to 970 ml of 50 mM NaH 2 PO 4 buffer (pH 6.20, adjusted with NaOH) containing 340 mg of Micrococcus luteus cells. The initial rate of decrease in absorbance at 540 nm was monitored at 25°C.
De®nitions of refolding ef®ciency and inhibitory activity
Refolding ef®ciency has been de®ned as the amount of the soluble proteins after refolding relative to the total proteins subjected to the refolding procedure, which has been calculated from the protein concentration quanti®ed by the BCA protein assay (Pierce). The inhibitory activity of the refolded protein toward the target protein, lysozyme, is relative to that of the secretory expressed (i.e. native) Fv fragment, which has been evaluated as described above. For instance, in the situation where the refolding ef®ciency and inhibitory activity are 50 and 100%, respectively, half of the proteins could be solubilized in the refolding buffer and the refolded soluble Fig. 2 . Chaperone-like activities of soluble mini-chaperone, DsbA and DsbC. Single-chain antibody was denatured in 6 M GdnHCl, 1 mM b-ME for more than 4 h at room temperature in the dark (scFv concentration, 15 mM), and then the concentration of denaturant was adjusted to 2 M as described in Materials and methods. For determination of enzyme activity, the absorbance at 320 nm was monitored with a Hitachi U3000 spectrophotometer after dilution of the denaturant to 0.5 M by a refolding solution (Wunderlich et al., 1994) . The refolding solution contained (a) GroEL(191±345) (mini-chaperone), (b) DsbA, (c) DsbC and (d) L-Arg. The ®nal concentration of scFv was 3 mM.
Immobilized oxidoreductase as an additive for refolding protein has almost identical inhibitory activity to the native Fv fragment.
Results
Bacterial expression, functional analyses and immobilization of the mini-chaperone, DsbA and DsbC Mini-chaperone, DsbA and DsbC were expressed and obtained as soluble proteins in ®nal yields of~90,~26 and~80 mg/l of culture, respectively. Gel ®ltration of the mini-chaperone showed that it was monomeric; it was fully functional in refolding a typical substrate, denatured carbonic anhydrase (data not shown).
Free thiol groups in expressed and puri®ed DsbA and DsbC constituted only 5% of all Cys groups, indicating that almost all the Dsbs were in the oxidized form. These disul®des were susceptible to excess reducing agent, e.g. dithiothreitol or b-ME. The disul®de isomerase activities of DsbA and DsbC were 6 and 8% relative to bovine protein disul®de isomerase, respectively, in the oxidized form, and 5 and 30%, respectively, in the reduced form.
For immobilized foldases, careful treatment of free thiol groups under an Ar atmosphere led to functional immobilization of DsbA and DsbC (data not shown) (Altamirano et al., 1999) . Free thiol groups in expressed and puri®ed, immobilized DsbA and DsbC also constituted 5% of all Cys groups, indicating that almost all of the immobilized Dsbs were in the oxidized form.
Prevention of scFv aggregation by soluble mini-chaperone, DsbA and DsbC in the dilution method Complete prevention of aggregation was achieved by dilution with the refolding buffer containing a 100-molar excess of the mini-chaperone to the substrate scFv (3 mM, Figure 2a ) and also by a 10-molar excess of DsbC (Figure 2c ). Incomplete prevention was observed at a 10-molar excess of DsbA (Figure 2b ), whose activity was somewhat lower than that of DsbC (Figure 2c ). L-Arg prevented aggregation at a concentration of 0.4 M ( Figure 2d ); GSSG and bovine serum albumin (BSA) did not prevent aggregation (data not shown). These results indicate that mini-chaperone, DsbA and DsbC have chaperone-like activity for scFv in a dose-dependent manner and that these foldases can recognize partially folded scFv as a substrate.
Prevention of aggregation and binding activity of scFv by soluble mini-chaperone, DsbA and DsbC in the stepwise dialysis method We next examined the effects of foldases on scFv aggregation during refolding in stepwise dialysis. Adding mini-chaperone to the refolding solution together with GSSG prevented aggregation at a concentration of 750 mM (i.e. 100-molar excess) (Figure 3a) . A 10-molar excess of DsbA and DsbC decreased aggregation (Figure 3b ), indicating that DsbA and DsbC functioned even at a GdnHCl concentration of 1 M. However, the scFv aggregation could not be completely prevented even by adding L-Arg (Figure 3c ). In contrast, the result of adding a 100-molar excess of the mini-chaperone to the refolding solution with DsbA completely prevented scFv aggregation, and furthermore, it should be noted for DsbC that the prevention of aggregation by the combination of the minichaperone (50-molar excess) with DsbC (10-molar excess) was more than just an additive effect caused by the coexistence of the mini-chaperone with DsbC. This suggests that the minichaperone in combination with oxidoreductases led to better refolding ef®ciency than with glutathione.
The function of the scFv refolded using foldases was assessed according to its ability to inhibit the enzymatic activity of its antigen, hen lysozyme (Table I ). The scFv that was refolded with mini-chaperone and GSSG recovered only 18% of its inhibitory activity relative to native Fv. However, scFv that was refolded with mini-chaperone and DsbC recovered 57% of its activity. In this study, the relative restoration of scFv's activity by the various treatments did not correctly correlate with their effectiveness in preventing aggregation.
Prevention of aggregation and binding activity of scFv by immobilized mini-chaperone, DsbA and DsbC in the stepwise dialysis method Figure 4 shows the refolding ef®ciency and the functional recovery of scFv by application of immobilized foldases (minichaperone, DsbA and DsbC) to the stepwise dialysis method. The refolding ef®ciency is the ratio of the soluble fraction at the ®nal stage in stepwise dialysis to the total amount of scFv used for refolding, and the functional recovery is estimated from the activity of the soluble scFv relative to that of native Fv. Addition of the mini-chaperone immobilized on agarose resin to the refolding solution along with GSSG only enhanced the refolding ef®ciency of scFv to a small degree in comparison with the case using only GSSG at each concentration of resin (samples a±d in Figure 4) . Furthermore, the refolding ef®-ciency of scFv using the immobilized mini-chaperone was lower than that using the non-immobilized (i.e. soluble) minichaperone (Figure 3) .
In contrast, the addition of immobilized DsbA and/or DsbC to scFv in the refolding solution led to a signi®cant increase in scFv refolding ef®ciency in the presence of L-Arg at an Table I . Inhibitory activity of HyHEL-10 scFv refolded in the presence of foldases
Sample
Inhibitory activity of the refolded protein (%) a 750 mM mini-chaperone, 375 mM GSSG 18 750 mM mini-chaperone, 75 mM DsbA 37 750 mM mini-chaperone, 75 mM DsbC 57 0.4 M L-Arg, 375 mM GSSG 67 a Equal molar amounts of anti-HEL scFv and hen lysozyme (1.5 mM) were mixed and incubated for 1 h at room temperature, and then the residual lysozyme activity was measured. The inhibitory activity of native Fv is de®ned as 100% and relative activities are shown. It should be noted that secretory expressed scFv has a reduced inhibitory activity (67%) (Tsumoto et al., 1994) , suggesting that the proteins refolded with 0.4 M L-Arg and 375 mM GSSG have almost identical activity to secretory expressed scFv. Refolding ef®ciency has been de®ned as the percentage of soluble proteins relative to the total proteins subjected to refolding, and inhibitory activity of the refolded protein is relative to that of the secretory expressed Fv.`1st round' shows the results 1 week after immobilization of the foldases;`2nd round' is after 1 month;`3rd round' is after 3 months.`Q10' means that a 10-molar excess of the corresponding immobilized protein was added to the denatured scFv. Each value is the average of at least three experiments. L-Arg,`+' means 0.4 M added. GSSG,`+' means 375 mM added. (a) Refolding ef®ciency; (b) inhibitory activity of the refolded protein.
Immobilized oxidoreductase as an additive for refolding equimolar concentration relative to the substrate scFv, in comparison with L-Arg alone (samples e, g and i in Figure 4) . At a 10-molar excess, the refolding ef®ciency and inhibitory activity were not changed by excess DsbA (sample h in Figure 4 ), while they were increased by excess DsbC (sample j in Figure 4 ). It should be noted that the enhancement of scFv refolding ef®ciency and inhibitory activity was substantially maintained even without L-Arg (samples m and n in Figure 4 ), since L-Arg must be added to the solution for ef®cient refolding of the scFv when DsbA or DsbC are used (Figure 3b and c) .
These results indicate that immobilized DsbA and DsbC can refold the denatured and reduced scFv with both relatively high yield and complete functional recovery. Gel ®ltration indicated that the scFv refolded under these conditions was monomeric (data not shown). We also measured the refolding of scFv using immobilized DsbC along with immobilized mini-chaperone (sample o in Figure 4 ). The refolding ef®ciency and inhibitory activity were similar to those where only immobilized DsbC was used (sample n in Figure 4 ).
Discussion
We describe the effects of foldases in refolding antibody fragments expressed in E.coli. First, mini-chaperone and two oxidoreductases derived from E.coli (DsbA and DsbC) could replace chemical reagents such as L-Arg and GSSG in the refolding procedure using the stepwise dialysis and were able to function even at GdnHCl concentrations >1 M. Secondly, immobilized oxidoreductases can also aid the refolding of antibody fragments. The soluble mini-chaperone prevented aggregation of scFv; however, a 100-molar excess of the mini-chaperone was required, and oxidants were required for functional recovery of the scFv. Goto and Hamaguchi (Goto and Hamaguchi, 1981) reported that spontaneous refolding did not lead to correct disul®de bond formation in the refolding of immunoglobulinfolded proteins without a redox shuf¯ing system of glutathione, and they found that free sul®de groups caused protein aggregation. The application of eukaryotic protein disul®de isomerase (PDI) to the in vitro folding system was also reported to increase the reactivation of antibody (Lilie et al., 1994) , and recently, Mayer et al. (Mayer et al., 2000) found that PDI acts synergistically with immunoglobulin heavy chain binding protein in the in vitro folding. Their report clearly supports our ®ndings that both chaperone activity and disul®de bond formation are required for refolding immunoglobulinfolded proteins. When L-Arg is present during refolding, the introduction of GSSG at the 1 and 0.5 M GdnHCl stages of dialysis resulted in the best refolding yield (Umetsu et al., 2003) However, in the presence of the mini-chaperone, the addition of an oxidoreductase, especially DsbC, resulted in a more complete binding activity than addition of GSSG ( Table I ), suggesting that disul®de bond shuf¯ing occurred. The fact that the L-Arg±DsbA (DsbC) refolding solution did not suppress aggregation of scFv might support the additional effect of the mini-chaperone for the oxidoreductase. Immobilization of GroEL is known to substantially decrease its chaperone activity (Taguchi et al., 1994) . In this study, we immobilized only the apical domain of GroEL, but the chaperone function was slightly decreased (samples b±d in Figure 4 ).
DsbA prevented aggregation of scFv at the 1 M GdnHCl stage during the refolding by stepwise dialysis, while DsbC could not prevent aggregation at the same stage (Figure 3b) . The chaperone-like activity of DsbA is evident from the ®nding that D-glyceraldehyde-3-phosphate dehydrogenase (GADPH) with triosephosphate isomerase (TIM) barrel fold can be refolded in the presence of DsbA despite it not having any disul®de bonds (Zheng et al., 1997) . With scFv, both the correct disul®de bond formation and the correct immunoglobulin-fold formation are required. The results reported here indicate that DsbA recognizes the denatured or partially folded scFv as a substrate, although this is not enough to achieve a high yield of correctly refolded scFv.
DsbC prevented aggregation of scFv almost completely at a 10-molar excess of DsbC to scFv (Figure 2c) , as suggested for GADPH (Chen et al., 1999) . DsbC acts as a disul®de bond isomerase for scFv, indicating its usefulness for refolding immunoglobulin-folded proteins. Thus, our results indicate that, in solution, DsbC is more useful than DsbA for refolding scFv, probably because the isomerase activity of soluble DsbA is lower than that of DsbC (Zheng et al., 1997; Chen et al., 1999) . However, immobilization of these oxidoreductases onto an agarose-based resin led to almost identical ef®ciencies in refolding scFv, perhaps due to an increase in the local concentration of DsbA.
Immobilization of oxidoreductases appeared to increase their stability dramatically: the activities of the immobilized isomerases were stable for more than a year, whereas these enzymes in solution do not retain activity for more than several months.
The inhibitory activity of scFv recovered from E.coli inclusion bodies with immobilized DsbC was almost the same as native Fv (sample n in Figure 4) , although the refolding ef®ciency was~60%. In contrast, the refolding system with GSSG and L-Arg achieves 100% refolding ef®ciency, but the inhibitory activity of refolded scFv is 67% of the activity of native Fv, which is the same activity as secretory expressed scFv (sample f in Figure 4) (Tsumoto et al., 1994; Umetsu et al., 2003) . Reconditioning activity has been proposed as a general property of refolding systems using immobilized foldases (Altamirano et al., 1997; . Therefore, our results suggested that more functional immunoglobulin-folded proteins can be obtained with immobilized disul®de isomerases than utilization of GSSG and L-Arg, while the immobilized DsbC prevents less aggregation of scFv. Whether secretory expressed or refolded, soluble fraction of scFv prepared might include molecules with reduced binding activity, and thus, reconditioning activity of immobilized disul®de isomerases may be critical for preparation of functional proteins with intra-and inter-molecular disul®de bonds.
Our results demonstrate that immobilized oxidoreductases may have the following advantages for refolding immunoglobulin-folded proteins (scFv): (i) smaller volumes than dilution or dialysis methods are needed; (ii) there is less use of chemical reagents such as L-Arg and glutathione, which are hard to recycle; (iii) immobilized oxidoreductases are reusable without the need for complicated separation methods; and (iv) more homogenous scFv with the same activity as native Fv. Because many proteins that are needed in large amounts for therapeutics and diagnosis have disul®de bonds, immobilized oxidoreductases would enable batch processing. Stabilization of oxidoreductases (PDIs) via protein engineering or utilization of oxidoreductases (PDIs) from thermophiles [e.g. Pyrococcus furious (Guagliardi et al., 1995) ] might improve immobilized oxidoreductases (PDIs). Finally, we would recommend the critical utilization of immobilized oxidoreductases as an effective additive for refolding several proteins with intraand inter-molecular disul®de bonds.
